As a traditional means of transportation, gasoline vehicles play an important role in people's lives. Its advantages include low cost, convenient maintenance, and a good driving experience. Suv Car,Medium Gasoline Passenger Car,Medium Suv Car,Small Gasoline Vehicle Chongqing Huanyu Automobile Sales Company , https://www.cqhuanyuauto.com
On the forum of good situation in the industry, Yu Mingde, executive vice president of the Chinese Pharmaceutical Industry Management Association pointed out that the current indications and data show that since 2007, the development of the pharmaceutical industry has improved, and the overall situation of the industry is improving.
Statistics show that from 2003 to 2006, the pharmaceutical industry sales profit rate (before tax) showed a straight downward trend. In 2003, the industry’s sales margin was 9.4%, 8.8% in 2004, 8.4% in 2005, and 7.98% in 2006. In this situation, the entire pharmaceutical industry has developed slowly. However, since 2007, the industry has shown a recovery trend. From January to August of 2007, the industry's sales profit rate has risen to 9.24%. From January to December 2007, the industry's sales profit rate has increased to 9.83%.
According to a conservative estimate of the China Pharmaceutical Enterprise Management Association, in 2007 the national pharmaceutical industry sales revenue exceeded 610 billion yuan, an increase of 23.7%; total profit is expected to exceed 60 billion yuan, an increase of 52.6%.
"It can be said that in 2007 the pharmaceutical industry has emerged from the predicament. In 2008 the pharmaceutical industry will develop better." Yu Mingde pointed out.
In Ming De's view, the three major factors promote the healthy development of the industry. First of all, the medical reform directly pulled the pharmaceutical industry out of the trough. In the context of the continuous improvement of the national economy, the people’s living standards have continued to increase. Statistics show that in 2007, the disposable income of urban residents (subtracting price factors) increased by 12.2%, and the disposable income of rural residents (subtracted by price factors) increased by 9.5%. The increase in the income of ordinary people will inevitably lead to medical and health consumption. The state's policy support for the “New Rural Cooperatives†and the urban residents’ medical insurance system has promoted the growth of the general medicine market.
Second, the competitive environment was purified. In 2007, the drug regulatory agency provided a fair, fair and open competitive environment for law-abiding businesses through on-site inspections, flight inspections, and spot checks, which actively promoted the healthy development of the industry.
Finally, the capital market will be further active in 2008. International capital from abroad has entered China's pharmaceutical industry in large numbers, and the trend of domestic companies going to the world is even more pronounced. In addition to “going out†through R&D outsourcing and transfer production, Chinese companies are striving to achieve the goal of formulation exports. The total consumption of drugs in the three major markets of the United States, the European Union, and Japan accounted for 88% of the world's total drug consumption - in the past only China's raw material drugs, there is no Chinese pharmaceutical preparations. However, “There are about forty to fifty companies in the country currently doing FDA certification, EU certification, and preparations for Japanese Ministry of Health and Welfare. It is expected that there will be a certification climax in the second half of 2009. More than a dozen or even more than two dozen companies are expected to The government certification in three regions has pushed China's preparations into the mainstream market."
“In 2007, there were 43 mergers and acquisitions in the national pharmaceutical industry, involving a total amount of RMB 3.4 billion. The mergers and acquisitions in the pharmaceutical sector will become more frequent in 2008. Pursuing the reintegration of resources and intensification of operations have become the main theme of mergers and acquisitions. The pharmaceutical industry in 2008 It will get the best development opportunities in the past five years," Yu Mingde said.
Enterprises are actively preparing. In fact, in the face of the current excellent situation, both multinational drug companies and domestic companies are actively preparing to rush to try.
Xian Janssen is a multinational company that produces non-prescription drugs.
It is reported that in response to the general trend of universal health care, Xi'an Janssen, who has always been on the high-end market, has set up a sales department for rural markets and urban community markets. His director of access, Guan Hui, has repeatedly appeared in public to consult with industry veterans about rural markets. Urban community market issues.
Zhu Jitao, chairman of the Fu Jen Pharmaceutical Group Pharmaceutical Co., Ltd., said that several years ago, Fu Jen Pharmaceuticals proposed the “Three Ones Project,†namely, “supporting one table to promote health care knowledge; The people use drugs more safely and effectively; extend their hands and provide assistance to the most basic people. To this end, they also wrote the "Red Book of Adverse Drug Reactions."
"We will carry out a series of activities centering on the "Red Book of Adverse Drug Reactions" to strengthen the training of grass-roots doctors and popularize the basic knowledge of drug use." Zhu Jitao said, "2008 will be a force for the development of Furen Pharmaceutical Group." In years, the space we can improve is definitely not just 10% or 20%, but it should be doubled."
Similar to Fu Jen Pharmaceuticals, Shenwei Pharmaceutical also devotes a great deal of effort to rural markets and urban community markets. However, as a listed company in Hong Kong, Shenwei Pharmaceutical's "attention" is by no means limited to this. Shenwei Pharmaceutical related sources said that the company has made considerable preparations for product R&D. At present, a clinical treatment project for cardiovascular and cerebrovascular diseases has been approved by the state as a new drug clinical approval, and clinical trials will begin immediately. "If all goes well, the product may be listed three years later."
At the same time, Shenwei Pharmaceutical will also conduct large-scale mergers and acquisitions in 2008. "We don't lack funds. The reason why we haven't started the acquisition project has been because we haven't found a suitable target. In 2008 we plan to acquire two companies. Of course, the object of the acquisition must meet two conditions, one is that The main body of the platform matches, and the second is the added value.†Shenwei Pharmaceutical relevant personage said, “We are aiming at the field of Chinese patent medicine, but it does not exclude the field of biomedicine – Shenwei itself will not develop biomedical products, but if you want If you are involved in the biomedical field, you can only achieve this goal through acquisitions."
For Suizhong Pharmaceutical, which has been on the cheap drug route, 2008 is undoubtedly the year of its efforts to transform. It is reported that "Zhongzhong" has been officially recognized as a national well-known trademark. For Suizhong Pharmaceutical, which has almost reached the limit of cost control, how to maintain a balance between low cost and good brands is obviously a new topic. It is said that Suizhong Pharmaceutical has begun to adjust its product structure and strive to produce truly high quality and low price products.
The popularity of gasoline cars is mainly due to their convenience and affordability. Compared to other fuel types of vehicles, gasoline vehicles have gas stations almost all over cities and rural areas, and the refueling process is relatively simple, taking only a few minutes to complete. In addition, gasoline vehicles have relatively low purchasing and maintenance costs, making them suitable for people with most household economic conditions to choose from.
The "Tenth China Pharmaceutical Enterprise Marketing Manager Summit Forum" hosted by the State Food and Drug Administration Training Center was held in Xi'an. Experts stated that in 2008, the pharmaceutical industry was in an all-round manner and pharmaceutical companies ushered in new opportunities for development.